IDEX BIOMETRICS ASA (IDEX.OL)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 1.5M 3M 4.5M FY19: 424K FY20: 1.1M FY21: 2.8M FY22: 4.1M FY23: 4.1M FY24: 841K FY19 FY20 FY21 FY22 FY23 FY24

Gross Profit Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Annual

-45M -30M -15M 0 15M 30M 45M FY19: -32M FY20: -26.4M FY21: -31.4M FY22: -31.4M FY23: -26.8M FY24: -21.9M FY19 FY20 FY21 FY22 FY23 FY24

Net Income Annual

-45M -30M -15M 0 15M 30M 45M FY19: -32.4M FY20: -26.8M FY21: -32.6M FY22: -32.7M FY23: -26.6M FY24: -14.4M FY19 FY20 FY21 FY22 FY23 FY24

Cost of Revenue Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Annual

-45M -30M -15M 0 15M 30M 45M FY19: -27.2M FY20: -23.3M FY21: -27.5M FY22: -31.4M FY23: -27M FY24: -17.5M FY19 FY20 FY21 FY22 FY23 FY24

Free Cash Flow Annual

-45M -30M -15M 0 15M 30M 45M FY19: -28M FY20: -23.4M FY21: -27.7M FY22: -31.6M FY23: -27.2M FY19 FY20 FY21 FY22 FY23

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.